Skip to main content
  • About Us
  • Investors
  • Careers
  • Contact us
Choose your market:
United Kingdom
  • Global / English
  • Albania / Gjuha shqipe
  • Algeria / Français
  • Argentina / Español
  • Australia / English
  • Austria / Deutsch
  • Bahrain / English
  • Belgium / English
  • Bolivia / Español
  • Bosnia-Herzegovina / BS
  • Bosnia-Herzegovina / EN
  • Brazil / Português
  • Bulgaria / Български
  • Canada / English
  • Canada / Français
  • Chile / Español
  • China / 简体中文
  • China / English
  • Colombia / Español
  • Costa Rica / Español
  • Croatia / Hrvatski jezik
  • Croatia / English
  • Cyprus / English
  • Czech Republic / český
  • Denmark / Dansk
  • Denmark / English
  • Dominican Republic / ES
  • Ecuador / Español
  • Egypt / English
  • El Salvador / Español
  • France / Français
  • Germany / Deutsch
  • Ghana / English
  • Guatemala / Español
  • Hong Kong SAR China / English
  • Hungary / Magyar nyelv
  • India / English
  • Indonesia / English
  • Iraq / English
  • Ireland / English
  • Israel / Hebrew
  • Italy / Italiano
  • Japan / 日本語
  • Jordan / English
  • Kazakhstan / Pусский
  • Kenya / English
  • Kosovo / Gjuha shqipe
  • Kosovo / Srpski
  • Kuwait / English
  • Lebanon / English
  • Macedonia / Македонски јазик
  • Macedonia / Gjuha shqipe
  • Malaysia / English
  • México / Español
  • Montenegro / Montenegrin
  • Morocco / Français
  • Mozambique / Portuguese
  • Netherlands / Nederlands
  • Netherlands / English
  • New Zealand / English
  • Nigeria / English
  • Norway / Norsk
  • Pakistan / English
  • Panama / Español
  • Peru / Español
  • Philippines / English
  • Poland / Polski
  • Portugal / Português
  • Puerto Rico / English
  • Qatar / English
  • Romania / Română
  • Romania / English
  • Russia / Pусский
  • Saudi Arabia / English
  • Serbia / Srpski
  • Singapore / English
  • Slovakia / Slovenský
  • Slovenia / Slovenščina
  • Slovenia / English
  • South Africa / English
  • South Korea / 한국어
  • Spain / Español
  • Sweden / Svenska
  • Switzerland / English
  • Switzerland / Deutsch
  • Taiwan / English
  • Tanzania / English
  • Thailand / English
  • Tunisia / Français
  • Türkiye / Türkçe
  • UAE / English
  • Uganda / English
  • Ukraine / Українська мова
  • Ukraine / English
  • United Kingdom / English
  • United States / English
  • Venezuela / Español
  • Vietnam / English
  • Zambia / English
  • News & Events
    • All
    • News & Polls
    • Events
    • Webinars
    • Newsletter
  • Innovation & Knowledge
    • All
    • Media & Brand Communication
    • Consumer & Shopper
    • Customer Experience
    • Society
    • New Services
  • Our Solutions
    • All
  • Ipsos.digital platform
  • ESG
  • About us
  • Investors
  • Careers
  • Contact us
  • Ipsos
  • Search

Search

Sort by Date Relevance
We found 11 results matching with your query. Refine by
  • Corporate

    30 Major Future Challenges in Evidence, Pricing & Access and How to Overcome Them

    Discover the 30 major Market Access challenges that will need to be overcome if, in a healthcare world that is evolving rapidly, real world outcomes are to meet the theoretical promises. 

    11 July 2023
  • Corporate

    Patient understanding of the treatment of their asthma across three continents and six countries

    Results from the new multi-country Annual Asthma Patient Survey reveal ongoing gaps in asthma care despite patient confidence in their asthma control

    2 May 2022
  • Corporate

    The Complexity of Patients with NSCLC with Brain Metastases Presents Significant Challenges for Oncologists

    Little data exists currently to understand the challenges and needs for non-small cell lung cancer (NSCLC) patients whose disease has metastasised to the brain. The European Cancer Organisation (ECO) representing 31 Member Societies and a Patient Advisory Committee comprising of 20 European patient groups commissioned research with Ipsos to share findings on this subject at their Roundtable event in October 2021.

    25 October 2021
  • Corporate

    Ipsos Research Highlights - February 2021

    In this week's Ipsos Research Highlights we share the latest interim findings from the REACT study, public perceptions of the Government’s handling of the pandemic and what Britons would do with excess vaccines.

    18 February 2021
  • Corporate

    Ipsos Research Highlights - November 2019

    This month's Ipsos research highlights include falling levels of concern over immigration, politicians are now the least trusted profession in Britain and the latest on the General Election as the majority expect the Conservatives to be the largest party.

    27 November 2019
  • Corporate

    Ipsos Research Highlights - March 2019

    Welcome to Highlights where we see Theresa May still struggling with Britain's withdrawal from the European Union, concern about crime increases and are we becoming more environmentally conscious?

    29 March 2019
  • Corporate

    Ipsos Research Highlights - September 2018

    Ipsos's Research Highlights for September 2018 includes a continued lack of confidence in party leaders, our reactions to fake news, the launch of Perils of Perception and attitudes towards the proposed opt-out system for organ donation.

    25 September 2018
  • Corporate

    Ipsos Research Highlights - August 2018

    Ipsos's Research Highlights for August 2018 includes young people's attitudes to immigration in Scotland, the results of the GP Patient Survey and people in Italy are most wrong on key facts about their society.

    31 August 2018
  • Corporate

    Patient-Centricity: Decoding The Buzzword

    No matter how you slice it, pharmaceutical companies across the industry are scrambling to be perceived as putting the patient first. But who is making good on this? What more needs to be done?

    20 September 2017
  • Corporate

    Harnessing Complexity: Companion Diagnostics in Oncology

    Companion diagnostics have had a profound impact on the way in which cancer is treated. In this article, Pieter De Richter – Ipsos Healthcare’s Head of Oncology Molecular Diagnostics – discusses how the promise of truly personalised medicine is edging closer towards reality.

    8 June 2017
Pagination
  • Current page 1
  • Next page >

Refine by

REFINE YOUR SEARCH FOR KEY WORD

  • (-) Innovation & Knowledge
    • Consumer & Shopper
    • (-) Corporate
    • Society
  • Citizens
  • Consumers & Brands
  • Customers & Employees
  • Doctors & Patients
  • Capabilities
  • About Us
  • Contact Us
  • Press
  • Investors
  • Careers
  • Face to Face Interviewer
© 2016 - 2025 Ipsos All Rights Reserved
  • Legal
  • Privacy & Data Protection
  • Cookie Policy
  • Tax Strategy
  • Modern Slavery Statement
  • Our Alert System